THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES
Conferences
Park, J; Lancero, H; Nasajpour, E; Garcia, C; Prolo, L; Grant, G; Petritsch, C
Published in: NEURO-ONCOLOGY
November 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2022
Volume
24
Start / End Page
34 / 34
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Park, J., Lancero, H., Nasajpour, E., Garcia, C., Prolo, L., Grant, G., & Petritsch, C. (2022). THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES. In NEURO-ONCOLOGY (Vol. 24, pp. 34–34).
Park, Jongwhi, Hope Lancero, Emon Nasajpour, Cesar Garcia, Laura Prolo, Gerald Grant, and Claudia Petritsch. “THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES.” In NEURO-ONCOLOGY, 24:34–34, 2022.
Park J, Lancero H, Nasajpour E, Garcia C, Prolo L, Grant G, et al. THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES. In: NEURO-ONCOLOGY. 2022. p. 34–34.
Park, Jongwhi, et al. “THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 34–34.
Park J, Lancero H, Nasajpour E, Garcia C, Prolo L, Grant G, Petritsch C. THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES. NEURO-ONCOLOGY. 2022. p. 34–34.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2022
Volume
24
Start / End Page
34 / 34
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis